News | April 13, 2022
BSV to set up vaccine manufacturing facility in Genome Valley
The total investment is in the region of Rs 200 crore
The total investment is in the region of Rs 200 crore
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
It is currently available in tablet and injectable dosage forms
Aquavit will officially unveil the Dermatox and Microtox programs at the Annual American Academy of Dermatology, the world's largest dermatology conference scheduled from March 25-29, 2022, in Boston, MA
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
The drug is indicated for use in combination with other drugs
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
The company plans to establish a state-of-the-art greenfield pharma facility with a total of 4-6 manufacturing units in different therapeutics categories to cater to domestic and export markets
Subscribe To Our Newsletter & Stay Updated
